The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 353.60
Bid: 354.80
Ask: 355.40
Change: 5.60 (1.61%)
Spread: 0.60 (0.169%)
Open: 350.20
High: 356.60
Low: 348.80
Prev. Close: 348.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investor Seminar

25 Oct 2023 07:23

RNS Number : 1762R
QinetiQ Group plc
25 October 2023
 

News release

QinetiQ Group plc

Investor Seminar: Drivers of our sustainable growth

25 October 2023 - QinetiQ Group plc ("QinetiQ" or "the Group") today is hosting a seminar where we will outline our overall strategy and drivers of our sustainable growth.

1.

UK Intelligence - a high growth £400m revenue business that has delivered 28% CAGR[1] over the last 4 years, well positioned as a critical partner to our UK defence and intelligence customers;

2.

United States - a $600m revenue disruptive mid-tier defence and intelligence business following our successful acquisition of Avantus last year, with significant growth momentum and a qualified pipeline of opportunities of over $2bn; and

3.

Australia including global threat representation - an A$400m revenue specialist advisory, engineering and threat representation products and services business with significant global growth opportunities.

The defence and security context worldwide has heightened the need for our six distinctive offerings giving significant growth potential within our >£30bn addressable market. We have delivered 9% organic revenue growth over the last four years, over twice the rate of growth in the defence budgets of our three home countries: the UK, US and Australia. Defence budgets are increasing around the world and we expect to continue delivering growth outpacing those budgets, driven by our structural alignment to high priority market segments that are increasing at faster rates.

Based upon our clear strategy and unique set of distinctive offerings, we have a robust plan to grow our company organically to £2.4bn revenue[2] at stable margins, with optionality for strategic acquisitions to reach our £3bn revenue2 ambition at 11-12% underlying operating profit margin and ROCE[3] at the upper end of the 15-20% range. We have a clear and robust capital allocation policy and are targeting to maintain a prudent balance sheet with leverage[4] under 1.5x. With capital intensity reducing we expect to see cash flow yields improve over the next few years.

The seminar will be presented at 101 Park Avenue in New York. You are invited to join us from 08:15 EDT to see a selection of our capabilities and products, as well as meet our leadership team. The presentation will start at 09:00 EDT (14:00 BST) and there will be an option to view online if you cannot join us in person. Access to the event is via registration on our website:

https://www.qinetiq.com/en/investors/investor-seminars/key-drivers-of-our-global-growth

A recording of the seminar will be available at www.QinetiQ.com/investors after the event. There will be no new material information disclosed on current trading.

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs more than 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Director Investor Relations:

+44 (0) 7920 545841

Lindsay Walls, Group Director Communications (Media enquiries):

+44 (0) 7793 427582

 


[1] Compound Annual Growth Rate (excluding disposals)

[2] In FY27

[3] Return on Capital Employed

[4] Net debt to EBITDA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEUEFLEDSELS
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
30th Apr 20244:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:01 amRNSDirectorate Change, Leadership Team appointments
16th Apr 20247:00 amRNSQinetiQ Group plc Fourth Quarter Trading Update
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20244:35 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSDirectorate Change
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:24 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20244:05 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20245:21 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.